IBDEI0AN ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4763,1,3,0)
 ;;=3^Diabetes Type 2 w/ Unspec Complications
 ;;^UTILITY(U,$J,358.3,4763,1,4,0)
 ;;=4^E11.8
 ;;^UTILITY(U,$J,358.3,4763,2)
 ;;=^5002665
 ;;^UTILITY(U,$J,358.3,4764,0)
 ;;=N18.1^^24^305^5
 ;;^UTILITY(U,$J,358.3,4764,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4764,1,3,0)
 ;;=3^Chr Kidney Disease,Stage 1
 ;;^UTILITY(U,$J,358.3,4764,1,4,0)
 ;;=4^N18.1
 ;;^UTILITY(U,$J,358.3,4764,2)
 ;;=^5015602
 ;;^UTILITY(U,$J,358.3,4765,0)
 ;;=N18.2^^24^305^6
 ;;^UTILITY(U,$J,358.3,4765,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4765,1,3,0)
 ;;=3^Chr Kidney Disease,Stage 2
 ;;^UTILITY(U,$J,358.3,4765,1,4,0)
 ;;=4^N18.2
 ;;^UTILITY(U,$J,358.3,4765,2)
 ;;=^5015603
 ;;^UTILITY(U,$J,358.3,4766,0)
 ;;=N18.3^^24^305^7
 ;;^UTILITY(U,$J,358.3,4766,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4766,1,3,0)
 ;;=3^Chr Kidney Disease,Stage 3
 ;;^UTILITY(U,$J,358.3,4766,1,4,0)
 ;;=4^N18.3
 ;;^UTILITY(U,$J,358.3,4766,2)
 ;;=^5015604
 ;;^UTILITY(U,$J,358.3,4767,0)
 ;;=N18.4^^24^305^8
 ;;^UTILITY(U,$J,358.3,4767,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4767,1,3,0)
 ;;=3^Chr Kidney Disease,Stage 4
 ;;^UTILITY(U,$J,358.3,4767,1,4,0)
 ;;=4^N18.4
 ;;^UTILITY(U,$J,358.3,4767,2)
 ;;=^5015605
 ;;^UTILITY(U,$J,358.3,4768,0)
 ;;=N18.5^^24^305^9
 ;;^UTILITY(U,$J,358.3,4768,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4768,1,3,0)
 ;;=3^Chr Kidney Disease,Stage 5
 ;;^UTILITY(U,$J,358.3,4768,1,4,0)
 ;;=4^N18.5
 ;;^UTILITY(U,$J,358.3,4768,2)
 ;;=^5015606
 ;;^UTILITY(U,$J,358.3,4769,0)
 ;;=N18.6^^24^305^87
 ;;^UTILITY(U,$J,358.3,4769,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4769,1,3,0)
 ;;=3^ESRD
 ;;^UTILITY(U,$J,358.3,4769,1,4,0)
 ;;=4^N18.6
 ;;^UTILITY(U,$J,358.3,4769,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,4770,0)
 ;;=N18.9^^24^305^10
 ;;^UTILITY(U,$J,358.3,4770,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4770,1,3,0)
 ;;=3^Chr Kidney Disease,Unspec
 ;;^UTILITY(U,$J,358.3,4770,1,4,0)
 ;;=4^N18.9
 ;;^UTILITY(U,$J,358.3,4770,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,4771,0)
 ;;=G54.1^^24^305^96
 ;;^UTILITY(U,$J,358.3,4771,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4771,1,3,0)
 ;;=3^Lumbosacral Plexus Disorders
 ;;^UTILITY(U,$J,358.3,4771,1,4,0)
 ;;=4^G54.1
 ;;^UTILITY(U,$J,358.3,4771,2)
 ;;=^5004008
 ;;^UTILITY(U,$J,358.3,4772,0)
 ;;=G56.11^^24^305^100
 ;;^UTILITY(U,$J,358.3,4772,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4772,1,3,0)
 ;;=3^Median Nerve Lesions,Right Upper Limb
 ;;^UTILITY(U,$J,358.3,4772,1,4,0)
 ;;=4^G56.11
 ;;^UTILITY(U,$J,358.3,4772,2)
 ;;=^5004021
 ;;^UTILITY(U,$J,358.3,4773,0)
 ;;=G56.12^^24^305^99
 ;;^UTILITY(U,$J,358.3,4773,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4773,1,3,0)
 ;;=3^Median Nerve Lesions,Left Upper Limb
 ;;^UTILITY(U,$J,358.3,4773,1,4,0)
 ;;=4^G56.12
 ;;^UTILITY(U,$J,358.3,4773,2)
 ;;=^5004022
 ;;^UTILITY(U,$J,358.3,4774,0)
 ;;=G56.21^^24^305^138
 ;;^UTILITY(U,$J,358.3,4774,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4774,1,3,0)
 ;;=3^Ulnar Nerve Lesion,Right Upper Limb
 ;;^UTILITY(U,$J,358.3,4774,1,4,0)
 ;;=4^G56.21
 ;;^UTILITY(U,$J,358.3,4774,2)
 ;;=^5004024
 ;;^UTILITY(U,$J,358.3,4775,0)
 ;;=G56.22^^24^305^137
 ;;^UTILITY(U,$J,358.3,4775,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4775,1,3,0)
 ;;=3^Ulnar Nerve Lesion,Left Upper Limb
 ;;^UTILITY(U,$J,358.3,4775,1,4,0)
 ;;=4^G56.22
 ;;^UTILITY(U,$J,358.3,4775,2)
 ;;=^5004025
 ;;^UTILITY(U,$J,358.3,4776,0)
 ;;=G56.31^^24^305^132
 ;;^UTILITY(U,$J,358.3,4776,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4776,1,3,0)
 ;;=3^Radial Nerve Lesion,Right Upper Limb
 ;;^UTILITY(U,$J,358.3,4776,1,4,0)
 ;;=4^G56.31
 ;;^UTILITY(U,$J,358.3,4776,2)
 ;;=^5004027
